Literature DB >> 761833

Reversal of ammonia coma in rats by L-dopa: a peripheral effect.

L Zieve, W M Doizaki, R F Derr.   

Abstract

Ammonia coma was produced in rats within 10 to 15 minutes of an intraperitonealinjection of 1.7 mmol NH4CL. This coma was prevented with 1.68 mmol L-dopa given by gastric intubation 15 minutes before the ammonium salt injection. The effect of L-dopa was correlated with a decrease in blood and brain ammonia, an increase in brain dopamine, and an increase in renal excretion of ammonia and urea. Intraventricular infusion of dopamine sufficient to raise the brain dopamine to the same extent did not prevent the ammonia coma nor affect the blood and brain ammonia concentrations. Bilateral nephrectomy eliminated the beneficial effect of L-dopa on blood and brain ammonia and the ammonia coma was not prevented. Thus, the reduction in blood and brain ammonia and the prevention of ammonia coma after L-dopa, can be accounted for by the peripheral effect of dopamine on renal function rather than its central action. These results provide a reasonable explanation for the beneficial effects observed in some encephalopathic patients receiving L-dopa.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 761833      PMCID: PMC1418965          DOI: 10.1136/gut.20.1.28

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

Authors:  R H MCDONALD; L I GOLDBERG; J L MCNAY; E P TUTTLE
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  Formation of artifactual ammonia in blood by action of alkali. Its significance for the measurement of blood ammonia.

Authors:  J G REINHOLD; C C CHUNG
Journal:  Clin Chem       Date:  1961-02       Impact factor: 8.327

3.  Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?

Authors:  L Zieve; R L Olsen
Journal:  Gut       Date:  1977-09       Impact factor: 23.059

4.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

5.  New high performance liquid chromatographic analysis of brain catecholamines.

Authors:  C Refshauge; P T Kissinger; R Dreiling; L Blank; R Freeman; R N Adams
Journal:  Life Sci       Date:  1974-01-16       Impact factor: 5.037

6.  Augmentation of sodium and potassium excretion, glomerular filtration rate and renal plasma flow by levodopa.

Authors:  G D Finlay; T L Whitsett; E A Cucinell; L I Goldberg
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

7.  The automated thiosemicarbazide-diacetyl monoxime method for plasma urea.

Authors:  A Mather; D Roland
Journal:  Clin Chem       Date:  1969-05       Impact factor: 8.327

8.  Levodopa in hepatic coma.

Authors:  J D Parkes; P Sharpstone; R Williams
Journal:  Lancet       Date:  1970-12-26       Impact factor: 79.321

9.  L-dopa in hepatic coma.

Authors:  J E Fischer; F J Funovics; H A Falcao; R I Wesdorp
Journal:  Ann Surg       Date:  1976-04       Impact factor: 12.969

  9 in total
  6 in total

Review 1.  Pathogenesis of hepatic encephalopathy.

Authors:  L Zieve
Journal:  Metab Brain Dis       Date:  1987-09       Impact factor: 3.584

2.  Decreased plasma isoleucine concentrations after upper gastrointestinal haemorrhage in humans.

Authors:  C H Dejong; W J Meijerink; C L van Berlo; N E Deutz; P B Soeters
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

Review 3.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

4.  Levodopa effect on norepinephrine and dopamine brain levels after portocaval shunt in rats.

Authors:  A Alsasua; J Arias; E Estebanez; M L Lopez-Sanchez; J I Arias; M Duran; P D Garcia de Jalon; H D Sacristan
Journal:  Experientia       Date:  1982-03-15

5.  Effect of L-dopa treatment on cerebral amino acid levels in rats after portocaval anastomosis.

Authors:  G Zanchin; P Rigotti; N Dussini; F Bettineschi; P Vassanelli; L Battistin
Journal:  Neurochem Res       Date:  1981-06       Impact factor: 3.996

6.  Hyperprolactinemia in portal systemic encephalopathy.

Authors:  C J McClain; J P Kromhout; M K Elson; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1981-04       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.